CEVAC - Ghent University and Ghent University Hospital jobs and careers

About CEVAC - Ghent University and Ghent University Hospital

CEVAC is a dedicated trial centre, specialized in vaccine research and conducting vaccine trials. It has a Clinical Trial Unit and an Immunology Lab. In recent decades, CEVAC has been involved in the development and evaluation of vaccines against hepatitis B, the first combined hepatitis A/B vaccine, a therapeutic hepatitis C vaccine, vaccines for HPV, herpes simplex viruses, HIV, tuberculosis, pertussis, influenza, group B streptococci, RSV, and more. In the Clinical Unit, our participants in various vaccine trials undergo study procedures each day. Most of our studies are commissioned by pharmaceutical companies. They are conducted in accordance with international standards of Good Clinical Practice (GCP). A team of about twenty employees - doctors, nurses, study coordinators and administrative staff - takes care of the study procedures. CEVAC’s Clinical Trial Unit has been leading vaccine research since 1995, handling projects from phase 1 to phase 4 with expertise. CEVAC’s immunomonitoring laboratory has been a fixed value in the field of vaccine research for many decades. Serving as a central laboratory in numerous multi- and monocentric, (inter)national vaccine trials, CEVAC Lab offers comprehensive support in processing various sample types and project management. CEVAC Lab is specialized in researching and measuring vaccine-induced immunity with a vast expertise in designing, developing, qualifying, and validating assays. Our portfolio includes assays for detecting and quantifying innate and adaptive, both humoral and cellular, immune responses. All activities are performed adhering to the highest quality standards and regulatory compliance, including GCLP guidelines.